NO20055655D0 - Anvendelse av azetidinkarboksamidderivater i terapi - Google Patents
Anvendelse av azetidinkarboksamidderivater i terapiInfo
- Publication number
- NO20055655D0 NO20055655D0 NO20055655A NO20055655A NO20055655D0 NO 20055655 D0 NO20055655 D0 NO 20055655D0 NO 20055655 A NO20055655 A NO 20055655A NO 20055655 A NO20055655 A NO 20055655A NO 20055655 D0 NO20055655 D0 NO 20055655D0
- Authority
- NO
- Norway
- Prior art keywords
- sup
- therapy
- azetidinecarboxamide
- derivatives
- aryl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0310057 | 2003-05-01 | ||
PCT/GB2004/001812 WO2004096209A1 (en) | 2003-05-01 | 2004-04-29 | The use of azetidinecarboxamide derivatives in therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20055655D0 true NO20055655D0 (no) | 2005-11-30 |
NO20055655L NO20055655L (no) | 2006-01-31 |
Family
ID=33397042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20055655A NO20055655L (no) | 2003-05-01 | 2005-11-30 | Anvendelse av azetidinkarboksamidderivater i terapi |
Country Status (16)
Country | Link |
---|---|
US (1) | US20060276452A1 (no) |
EP (1) | EP1617839B1 (no) |
JP (1) | JP2006525297A (no) |
KR (1) | KR20060017763A (no) |
CN (1) | CN1780615A (no) |
AT (1) | ATE398449T1 (no) |
AU (1) | AU2004233644A1 (no) |
BR (1) | BRPI0409959A (no) |
CA (1) | CA2524245A1 (no) |
DE (1) | DE602004014484D1 (no) |
EA (1) | EA200501703A1 (no) |
MX (1) | MXPA05011472A (no) |
NO (1) | NO20055655L (no) |
NZ (1) | NZ543322A (no) |
WO (1) | WO2004096209A1 (no) |
ZA (1) | ZA200508835B (no) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060010770A (ko) * | 2003-05-01 | 2006-02-02 | 베르날리스 리서치 리미티드 | 아제티딘카르복스아미드 유도체와 씨비1 수용체로 매개된질병의 치료에 대한 이들의 용도 |
NZ564759A (en) * | 2005-06-30 | 2011-08-26 | Prosidion Ltd | GPCR agonists |
EP1907384A2 (en) * | 2005-06-30 | 2008-04-09 | Prosidion Limited | Gpcr agonists |
WO2007102999A2 (en) * | 2006-02-21 | 2007-09-13 | Ampla Pharmaceuticals Inc. | Cb1 antagonists and inverse agonists |
AU2007283113A1 (en) | 2006-08-08 | 2008-02-14 | Sanofi-Aventis | Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use |
EP2025674A1 (de) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
CA2771278A1 (en) | 2009-08-26 | 2011-03-03 | Sanofi | Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use |
EP2582709B1 (de) | 2010-06-18 | 2018-01-24 | Sanofi | Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen |
US8828994B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8809324B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
WO2012120058A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120057A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
US8809325B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof |
EP2683699B1 (de) | 2011-03-08 | 2015-06-24 | Sanofi | Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
WO2012120052A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung |
WO2012120053A1 (de) | 2011-03-08 | 2012-09-13 | Sanofi | Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung |
US11141404B1 (en) | 2020-11-18 | 2021-10-12 | Anebulo Pharmaceuticals, Inc. | Formulations and methods for treating acute cannabinoid overdose |
CA3234167A1 (en) * | 2021-10-11 | 2023-04-20 | Joseph Fenton Lawler | Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4261990A (en) * | 1979-03-09 | 1981-04-14 | Ciba-Geigy Corporation | N-alkyleneiminoalkyl-dicarboximides as antiallergics and antiasthmatics |
JPH03264562A (ja) * | 1989-05-22 | 1991-11-25 | Hokuriku Seiyaku Co Ltd | ピペリジン誘導体 |
JP3194355B2 (ja) * | 1996-10-24 | 2001-07-30 | 宇部興産株式会社 | ピペリジン化合物及びその製法 |
DE69911373T2 (de) * | 1998-01-23 | 2004-07-01 | Vernalis Research Ltd., Winnersh | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen |
GB9917386D0 (en) * | 1999-07-23 | 1999-09-22 | Cerebrus Ltd | Chemical compounds-II |
FR2805817B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation |
US6566356B2 (en) * | 2000-03-03 | 2003-05-20 | Aventis Pharma S.A. | Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation |
FR2805810B1 (fr) * | 2000-03-03 | 2002-04-26 | Aventis Pharma Sa | Compositions pharmaceutiques contenant des derives de 3- amino-azetidine, les nouveaux derives et leur preparation |
KR20060010770A (ko) * | 2003-05-01 | 2006-02-02 | 베르날리스 리서치 리미티드 | 아제티딘카르복스아미드 유도체와 씨비1 수용체로 매개된질병의 치료에 대한 이들의 용도 |
-
2004
- 2004-04-29 CN CNA2004800117556A patent/CN1780615A/zh active Pending
- 2004-04-29 BR BRPI0409959-1A patent/BRPI0409959A/pt not_active IP Right Cessation
- 2004-04-29 JP JP2006506193A patent/JP2006525297A/ja active Pending
- 2004-04-29 NZ NZ543322A patent/NZ543322A/xx unknown
- 2004-04-29 EP EP04730286A patent/EP1617839B1/en not_active Expired - Lifetime
- 2004-04-29 DE DE602004014484T patent/DE602004014484D1/de not_active Expired - Fee Related
- 2004-04-29 WO PCT/GB2004/001812 patent/WO2004096209A1/en active IP Right Grant
- 2004-04-29 CA CA002524245A patent/CA2524245A1/en not_active Abandoned
- 2004-04-29 KR KR1020057020651A patent/KR20060017763A/ko not_active Application Discontinuation
- 2004-04-29 MX MXPA05011472A patent/MXPA05011472A/es active IP Right Grant
- 2004-04-29 EA EA200501703A patent/EA200501703A1/ru unknown
- 2004-04-29 US US10/552,574 patent/US20060276452A1/en not_active Abandoned
- 2004-04-29 AT AT04730286T patent/ATE398449T1/de not_active IP Right Cessation
- 2004-04-29 AU AU2004233644A patent/AU2004233644A1/en not_active Abandoned
-
2005
- 2005-10-31 ZA ZA200508835A patent/ZA200508835B/en unknown
- 2005-11-30 NO NO20055655A patent/NO20055655L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0409959A (pt) | 2006-04-25 |
EA200501703A1 (ru) | 2006-06-30 |
NZ543322A (en) | 2009-03-31 |
DE602004014484D1 (de) | 2008-07-31 |
EP1617839B1 (en) | 2008-06-18 |
ZA200508835B (en) | 2006-12-27 |
NO20055655L (no) | 2006-01-31 |
EP1617839A1 (en) | 2006-01-25 |
AU2004233644A1 (en) | 2004-11-11 |
CN1780615A (zh) | 2006-05-31 |
WO2004096209A1 (en) | 2004-11-11 |
ATE398449T1 (de) | 2008-07-15 |
JP2006525297A (ja) | 2006-11-09 |
CA2524245A1 (en) | 2004-11-11 |
KR20060017763A (ko) | 2006-02-27 |
US20060276452A1 (en) | 2006-12-07 |
MXPA05011472A (es) | 2005-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20055655D0 (no) | Anvendelse av azetidinkarboksamidderivater i terapi | |
EA200501585A1 (ru) | Производные азетидинкарбоксамида и их применение при лечении нарушений, опосредованных св1 рецепторами | |
HK1091121A1 (en) | Substituted 2-aminotetralins for the treatment of depressions | |
IS8502A (is) | Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar | |
ATE440603T1 (de) | 8-hydroxychinolinderivate | |
CA2478374A1 (en) | N3 alkylated benzimidazole derivatives as mek inhibitors | |
MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
HRP20090281T1 (en) | 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases | |
WO2005023759A3 (en) | Heterocyclic inhibitors of mek and methods of use thereof | |
CY1107974T1 (el) | Παραγωγα κινολινης και κιναζολινης εχοντα συναφεια προς τους υποδοχεις τυπου 5ht1 | |
MY140638A (en) | New heterocyclic compounds, which are active as inhibitors of beta-lactamases | |
ATE384058T1 (de) | Thiazolderivate | |
ATE341550T1 (de) | Quinolinyl-pyrrolopyrazole | |
ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
SE0402762D0 (sv) | Indazole sulphonamide derivatives | |
GEP20063751B (en) | 2-Acyl Indol Derivatives and Their Use as Anti-Tumour Agents | |
DE60045508D1 (de) | Dalda-analoge und ihre verwendung | |
DE60305514D1 (de) | Neue verwendung von benzothiazolderivaten | |
ATE279192T1 (de) | Die verwendung eines benzimidazoles zur herstellung eines medikamentes zur krebsvorbeugung | |
SE0302573D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
SE0301701D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
IL195016A0 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
MXPA05005790A (es) | Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central. | |
MY139676A (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |